Martinelli, Filippo
Heinken, Almut
Henning, Ann-Kristin
Ulmer, Maria A.
Hensen, Tim
González, Antonio
Arnold, Matthias
Asthana, Sanjay
Budde, Kathrin
Engelman, Corinne D.
Estaki, Mehrbod
Grabe, Hans-Jörgen
Heston, Margo B.
Johnson, Sterling
Kastenmüller, Gabi
Martino, Cameron
McDonald, Daniel
Rey, Federico E.
Kilimann, Ingo
Peters, Olive
Wang, Xiao
Spruth, Eike Jakob
Schneider, Anja
Fliessbach, Klaus
Wiltfang, Jens
Hansen, Niels
Glanz, Wenzel
Buerger, Katharina
Janowitz, Daniel
Laske, Christoph
Munk, Matthias H.
Spottke, Annika
Roy, Nina
Nauck, Matthias
Teipel, Stefan
Knight, Rob
Kaddurah-Daouk, Rima F.
Bendlin, Barbara B.
Hertel, Johannes
Thiele, Ines
Funding for this research was provided by:
National Institute on Aging
National Institute of General Medical Sciences
Foundation for the National Institutes of Health
European Research Council
Science Foundation Ireland
Article History
Received: 29 August 2023
Accepted: 29 February 2024
First Online: 13 March 2024
Competing interests
: G.K. and M.A. are co-inventors of several patent applications on the use of metabolomics in Alzheimer’s disease and own equity and IP in Chymia LLC and IP in PsyProtix unrelated to this work. R.K.D. is an inventor of a series of patents on the use of metabolomics for the diagnosis and treatment of CNS diseases and holds equity in Metabolon Inc., Chymia LLC and PsyProtix. S.T. has served on national and international advisory boards of Roche, Eisai, Grifols, and Biogen, and is a member of the independent data safety and monitoring board of the study ENVISION (Biogen). H.J.G. has received travel grants and speaker’s honoraria from Fresenius Medical Care, Neuraxpharm, Servier, and Janssen Cilag as well as research funding from Fresenius Medical Care. R.K. is a scientific advisory board member, and consultant for BiomeSense, Inc., has equity and receives income. He is a scientific advisory board member and has equity in GenCirq. He is a consultant and scientific advisory board member for DayTwo, and receives income. He has equity in and acts as a consultant for Cybele. He is a co-founder of Biota, Inc., and has equity. He is a cofounder of Micronoma, and has equity and is a scientific advisory board member. D.M. is a consultant for, and has stock in, BiomeSense, Inc. The terms of these arrangements have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies.